Product Program year 2020 Source: CMS Open Payments

Omnilink Elite vascular stent system

Device Vascular

Open in the dashboard

General payments

$1,310,665

2,782 payments

Research payments

$15,000

1 payment

Through program year 2020, $1,310,665 in general payments and $15,000 in research payments were reported against Omnilink Elite vascular stent system (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 General $527,058 1,242
2020 Research $15,000 1
2019 General $783,608 1,540

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $1,310,665 2,782 payments
Top recipients General payments · program year 2020
  1. Prakash Krishnan Interventional Cardiology · New York, NY $44,758 8% · 32 payments
  2. Foluso Fakorede Interventional Cardiology · Cleveland, MS $28,081 5% · 15 payments
  3. David Metzger Cardiovascular Disease · Kingsport, TN $24,200 5% · 3 payments
  4. Christian Bianchi Surgery · Loma Linda, CA $20,058 4% · 15 payments
  5. George Adams Interventional Cardiology · Garner, NC $16,250 3% · 6 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Interventional Cardiology Internal Medicine $225,929 44% · 97 practitioners
  2. Cardiovascular Disease Internal Medicine $106,965 21% · 55 practitioners
  3. Vascular Surgery Surgery $78,980 15% · 39 practitioners
  4. Vascular & Interventional Radiology Radiology $37,350 7% · 25 practitioners
  5. Surgery $34,270 7% · 4 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. New York $110,492 21% · 21 recipients
  2. Florida $54,227 10% · 32 recipients
  3. California $50,302 10% · 18 recipients
  4. Mississippi $34,895 7% · 7 recipients
  5. Texas $30,774 6% · 18 recipients

The top 5 of 36 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

2,782 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record